Cangene today announces that its U.S. distributor for HepaGam B(TM), Apotex Corp., has signed a five-year agreement with Novation, LLC for distribution of Cangene's hepatitis B hyperimmune under the NOVAPLUS(R) private-label program. Novation is a leading healthcare contract-services company and supplies nearly 2,500 healthcare organizations in the United States.
Read the full story
